ID: ALA192056

Max Phase: Preclinical

Molecular Formula: C18H19FO

Molecular Weight: 270.35

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccc(/C=C\c2cc(C)c(C)c(C)c2)cc1F

Standard InChI:  InChI=1S/C18H19FO/c1-12-9-16(10-13(2)14(12)3)6-5-15-7-8-18(20-4)17(19)11-15/h5-11H,1-4H3/b6-5-

Standard InChI Key:  MZVXBMQFWPMYED-WAYWQWQTSA-N

Associated Targets(Human)

Tubulin beta-1 chain 182 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 270.35Molecular Weight (Monoisotopic): 270.1420AlogP: 4.93#Rotatable Bonds: 3
Polar Surface Area: 9.23Molecular Species: NEUTRALHBA: 1HBD: 0
#RO5 Violations: 0HBA (Lipinski): 1HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 5.84CX LogD: 5.84
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.72Np Likeness Score: -0.44

References

1. Ducki S, Mackenzie G, Lawrence NJ, Snyder JP..  (2005)  Quantitative structure-activity relationship (5D-QSAR) study of combretastatin-like analogues as inhibitors of tubulin assembly.,  48  (2): [PMID:15658859] [10.1021/jm049444m]

Source